Why the study?
Does generic nafamostat mesilate compared to brand-name nafamostat mesilate affect the amount of precipitates in the hemodialysis circuit and anticoagulant effect in maintenance hemodialysis patients?
Does generic nafamostat mesilate compared to brand-name nafamostat mesilate affect the amount of precipitates in the hemodialysis circuit and anticoagulant effect in maintenance hemodialysis patients?
Answers are grounded in this paper and cite their sources.
Generic nafamostat mesilate may cause significantly more precipitates in the hemodialysis circuit compared to the brand-name version, highlighting the need for caution when switching to generics.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hirashima et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: